Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1994 | 06-1994 | 03-1994 | 12-1993 | 09-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,701 | 2,378 | 1,936 | 2,362 | 3,555 |
| Receivables | 278 | 79 | 165 | 353 | 180 |
| Other current assets | 53 | 98 | 123 | 194 | 111 |
| TOTAL | $2,032 | $2,555 | $2,224 | $2,909 | $3,846 |
| Non-Current Assets | |||||
| PPE Net | N/A | 157 | 157 | 157 | 156 |
| Other Non-Current Assets | 0 | 20 | 20 | 20 | 20 |
| TOTAL | $N/A | $177 | $177 | $177 | $176 |
| Total Assets | $2,120 | $2,650 | $2,324 | $3,016 | $3,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 181 | 160 | 429 | 284 | 411 |
| Accrued Expenses | N/A | 35 | 553 | 588 | 423 |
| Other current liabilities | N/A | 44 | 58 | 98 | 20 |
| TOTAL | $230 | $239 | $1,040 | $970 | $854 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 15 | 15 | 16 | 17 |
| TOTAL | $N/A | $15 | $15 | $16 | $17 |
| Total Liabilities | $243 | $254 | $1,055 | $986 | $871 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 342 | 341 | 341 | 337 |
| Retained earnings | N/A | -38,063 | -39,179 | -38,408 | -37,219 |
| Other shareholders' equity | 1,877 | -5 | -5 | -5 | -5 |
| TOTAL | $1,877 | $2,396 | $1,269 | $2,030 | $3,088 |
| Total Liabilities And Equity | $2,120 | $2,650 | $2,324 | $3,016 | $3,959 |